Relmada Therapeutics Filing Effectiveness Noted
Ticker: RLMD · Form: EFFECT · Filed: 2026-04-10T00:15:17-04:00
Sentiment: neutral
Topics: registration-statement, effectiveness, filing-update
TL;DR
Relmada's registration statement is now effective as of 4/9/2026.
AI Summary
Relmada Therapeutics, Inc. filed an EFFECT form on April 10, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9999999995-26-001136, relates to Act 33 and File No. 333-294885. The effectiveness date was April 9, 2026.
Why It Matters
This filing signifies that a registration statement for Relmada Therapeutics, Inc. has become effective, which is a crucial step for certain securities offerings or corporate actions.
Risk Assessment
Risk Level: low — This is a routine administrative filing indicating the effectiveness of a registration statement, not a material event like an acquisition or earnings miss.
Key Numbers
- 2026-04-09 — Effectiveness Date (The date the registration statement became effective.)
- 2026-04-10 — Filing Date (The date the filing was accepted by the SEC.)
Key Players & Entities
- Relmada Therapeutics, Inc. (company) — Filer
- 9999999995-26-001136 (dollar_amount) — SEC Accession Number
- 2026-04-10 (dollar_amount) — Filing Acceptance Date
- 2026-04-09 (dollar_amount) — Effectiveness Date
- 333-294885 (dollar_amount) — File Number
FAQ
What type of filing is this?
This is an EFFECT filing, which indicates the effectiveness of a registration statement.
Who is the filer?
The filer is Relmada Therapeutics, Inc. (CIK: 0001553643).
When did the registration statement become effective?
The registration statement became effective on April 9, 2026.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 9999999995-26-001136.
What is the File Number associated with this filing?
The File Number is 333-294885.
From the Filing
EDGAR Filing Documents for 9999999995-26-001136 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001136 Accepted 2026-04-10 00:15:17 Documents 1 Effectiveness Date 2026-04-09 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 596 Complete submission text file 9999999995-26-001136.txt 1843 Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459 RELMADA THERAPEUTICS, INC. (Filer) CIK : 0001553643 (see all company filings) EIN. : 455401931 | State of Incorp.: NV | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-294885 | Film No.: 26853029 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)